In high-risk type 2 diabetes, adding oral semaglutide to standard care reduced MACE at a mean 48 mo

Jun 30, 2025Annals of internal medicine

Adding oral semaglutide to usual treatment lowers major heart and blood vessel problems in high-risk type 2 diabetes over about 4 years

AI simplified

Abstract

The abstract presents multiple specialized formulas related to cardiology, endocrinology, and nephrology.

  • Formulas for different medical fields may provide insights into patient care.
  • Cardiology formulas focus on heart-related metrics and their implications.
  • Endocrinology formulas address hormonal functions and their effects on health.
  • Nephrology formulas relate to kidney function and associated disorders.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free